Skip to main content
. 2021 Jun 4;14(6):e243360. doi: 10.1136/bcr-2021-243360

Figure 3.

Figure 3

The clinical course of a 57-year-old man with the simultaneous occurrence of autoimmune pancreatitis and sclerosing cholangitis as immune-related adverse events. CBDCA, carboplatin; nab-PTX, nanoparticle albumin-bound-paclitaxel; ALT, alanine aminotransferase; ALP, alkaline phosphatase; AMY, amylase; NM, nafamostat mesylate; PSL, prednisolone; mPSL, methylprednisolone; UDCA, ursodeoxycholic acid.